Agenus Inc., a medical-phase biotechnology company, discovers and develops therapies to activate the body's immune method towards most cancers and infections in the United States and internationally. It offers Retrocyte Exhibit, an antibody expression System to the identification of fully human and humanized monoclonal antibodies; and Show systems.